Amy is a life sciences executive who is passionate about helping to build innovative companies. She joined NIS from the diagnostics industry, where she was President of BioPorto Diagnostics, and President and CEO of Magellan Diagnostics. Prior to Magellan, Amy held a variety of marketing leadership roles at C.R. Bard, Athena Diagnostics, and Primedica, a preclinical CRO that is now part of Charles River Labs. She has a BA in Biology from Brown University and an MBA from Harvard Business School.